MT-CYB and viral infectious disease: The release of mitochondrial protein enzymes such as oxidase components MT-CO2 and CYB, CYTB or CYP into circulation were consistent with cellular damage from viral infection that might be quantified by enzyme activity to serve as a prognostic marker for the severity of COVID-19 infection [67].